Hillsdale Investment Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,300
Closed -$515K 619
2022
Q3
$515K Buy
+7,300
New +$625K 0.05% 317
2022
Q1
Sell
-7,400
Closed -$676K 613
2021
Q4
$676K Sell
7,400
-800
-10% -$85.8K 0.05% 321
2021
Q3
$1.05M Sell
8,200
-500
-6% -$70K 0.08% 222
2021
Q2
$1.33M Buy
+8,700
New +$1.15M 0.11% 179
2019
Q2
Sell
-44,100
Closed -$1.51M 670
2019
Q1
$1.51M Hold
44,100
0.14% 142
2018
Q4
$1.41M Buy
44,100
+3,000
+7% +$117K 0.17% 140
2018
Q3
$1.97M Buy
41,100
+38,000
+1,226% +$1.56M 0.26% 59
2018
Q2
$96K Buy
+3,100
New +$72.5K 0.01% 298

Other funds holding STAA

Hillsdale Investment Management's STAA Position: Q4 2022 in Review

Hillsdale Investment Management sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 7,300 shares — an estimated $515K sold.

Hillsdale Investment Management first reported a position in STAA in Q2 2018 and held it in 8 quarters. The position peaked at $1.97M in Q3 2018. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

  • Hillsdale Investment Management reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 7,300 STAAR Surgical shares in Q4 2022, an estimated $515K.
  • Hillsdale Investment Management first reported a position in STAAR Surgical in Q2 2018 and held it in 8 quarters.
  • Hillsdale Investment Management's STAAR Surgical position peaked at $1.97M in Q3 2018.
  • 275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on Hillsdale Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.